Linked Life Data

15690639

Source:http://linkedlifedata.com/resource/pubmed/id/15690639

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-2-4
pubmed:abstractText
Acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) not only are the most common cancer in children, but also among the most curable. Contemporary therapy has achieved highly successful survival rates by risk stratification into low- and high-risk treatment groups. This has permitted tailoring therapy intensity to produce higher remission rates, even in unfavorable prognostic groups. Accurate diagnosis, subclassification, and identification of relevant prognostic factors for lymphoblastic malignant neoplasms, using a multiparametric approach including immunophenotyping, cytogenetic and molecular analysis, and more traditional pathologic criteria, provides information that allows each patient to receive appropriate treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-9173
pubmed:author
pubmed:issnType
Print
pubmed:volume
122 Suppl
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S3-18
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms.
pubmed:affiliation
Department of Pathology, University of Utah Health Sciences Center and ARUP Laboratories, Salt Lake City 84132, USA.
pubmed:publicationType
Journal Article, Review